Bacterial lantibiotics: strategies to improve therapeutic potential.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current protein and peptide science

• Publication date

  2005-01-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389203053027584PMID 15638769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50.

  2004cited by this paper
• Lacticin 481: In Vitro Reconstitution of Lantibiotic Synthetase Activity

  2004cited by this paper
• Construction of an Expression System for Site-Directed Mutagenesis of the Lantibiotic Mersacidin

  2003cited by this paper
• Structure and dynamics of the lantibiotic mutacin 1140.

  2003cited by this paper
• Purification and Characterization of Streptin, a Type A1 Lantibiotic Produced by Streptococcus pyogenes

  2003cited by this paper
• NMR Study of Mersacidin and Lipid II Interaction in Dodecylphosphocholine Micelles

  2003cited by this paper
• Bacteriocin Detection from Whole Bacteria by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

  2003cited by this paper
• SpaC and NisC, the cyclases involved in subtilin and nisin biosynthesis, are zinc proteins.

  2003cited by this paper
• Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005

  2003cited by this paper
• The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells

  2003cited by this paper
• Lipid II Is an Intrinsic Component of the Pore Induced by Nisin in Bacterial Membranes*

  2003cited by this paper
• Lantibiotics produced by lactic acid bacteria: structure, function and applications

  2002cited by this paper
• Electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry to reveal the substrate specificity of the peptidyl-cysteine decarboxylase EpiD.

  2002cited by this paper
• Multiple activities in lantibiotics--models for the design of novel antibiotics?

  2002cited by this paper
• Distribution of Genes Encoding the Trypsin-Dependent Lantibiotic Ruminococcin A among Bacteria Isolated from Human Fecal Microbiota

  2002cited by this paper
• Heterologous expression and purification of SpaB involved in subtilin biosynthesis.

  2002cited by this paper
• Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.

  2002cited by this paper
• NisB is required for the dehydration and NisC for the lanthionine formation in the post-translational modification of nisin.

  2002cited by this paper
• Genetically modified Streptococcus mutans for the prevention of dental caries

  2002cited by this paper
• Trypsin Mediates Growth Phase-Dependent Transcriptional Regulation of Genes Involved in Biosynthesis of Ruminococcin A, a Lantibiotic Produced by a Ruminococcus gnavus Strain from a Human Intestinal Microbiota

  2002cited by this paper
• Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin.

  2002cited by this paper
• Thiol-Disulfide Oxidoreductases Are Essential for the Production of the Lantibiotic Sublancin 168*

  2002cited by this paper
• The Flavoprotein MrsD Catalyzes the Oxidative Decarboxylation Reaction Involved in Formation of the Peptidoglycan Biosynthesis Inhibitor Mersacidin

  2002cited by this paper
• Two Different Lantibiotic-Like Peptides Originate from the Ericin Gene Cluster of Bacillus subtilis A1/3

  2002cited by this paper
• Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: Minimal structural requirements for intermolecular complexation and fibril formation

  2002cited by this paper
• Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic.

  2001cited by this paper
• Lantibiotics: structure, biosynthesis and mode of action.

  2001cited by this paper
• Intra- and Interspecies Signaling betweenStreptococcus salivarius and Streptococcus pyogenes Mediated by SalA and SalA1 Lantibiotic Peptides

  2001cited by this paper
• Bacteriocins: safe, natural antimicrobials for food preservation.

  2001cited by this paper
• Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity*

  2001cited by this paper
• Biochemical Structural Analysis of the Lantibiotic Mutacin II*

  2000cited by this paper
• Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.

  2000cited by this paper
• Ab initio structure determination of the lantibiotic mersacidin.

  2000cited by this paper
• Engineering a disulfide bond and free thiols in the lantibiotic nisin Z.

  2000cited by this paper
• Lantibiotics and microcins: polypeptides with unusual chemical diversity.

  2000cited by this paper
• Lantibiotic Biosynthesis: Interactions between Prelacticin 481 and Its Putative Modification Enzyme, LctM

  2000cited by this paper
• In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.

  2000cited by this paper
• Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147.

  2000cited by this paper
• Lacticin 3147 displays activity in buffer against Gram‐positive bacterial pathogens which appear insensitive in standard plate assays

  1999cited by this paper
• Purification of Mutacin III from Group IIIStreptococcus mutans UA787 and Genetic Analyses of Mutacin III Biosynthesis Genes

  1999cited by this paper
• The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows.

  1999cited by this paper
• Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

  1999cited by this paper
• Developing applications for lactococcal bacteriocins

  1999cited by this paper
• The orientation of nisin in membranes.

  1998cited by this paper
• Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.

  1998cited by this paper
• Structure-Activity Study of the Lantibiotic Mutacin II from Streptococcus mutans T8 by a Gene Replacement Strategy

  1998cited by this paper
• The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II

  1998cited by this paper
• Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model.

  1998cited by this paper
• Evaluation of Lacticin 3147 and a Teat Seal Containing This Bacteriocin for Inhibition of Mastitis Pathogens

  1998cited by this paper
• Identification and Characterization of the Structural and Transporter Genes for, and the Chemical and Biological Properties of, Sublancin 168, a Novel Lantibiotic Produced by Bacillus subtilis 168*

  1998cited by this paper
• Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.

  1998cited by this paper
• Genetic and Biochemical Analysis of Mutacin 1140, a Lantibiotic from Streptococcus mutans

  1998cited by this paper
• Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics

  1998cited by this paper
• Purification and structure of mutacin B‐Ny266: a new lantibiotic produced by Streptococcus mutans

  1997cited by this paper
• The Effect of Nisin and Monensin on Ruminal Fermentations In Vitro

  1997cited by this paper
• The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.

  1997cited by this paper
• Activity of nisin against Clostridium difficile.

  1997cited by this paper
• The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.

  1997cited by this paper
• Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity.

  1997cited by this paper
• In vivo reaction of affinity-tag-labelled epidermin precursor peptide with flavoenzyme EpiD.

  1997cited by this paper
• Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.

  1997cited by this paper
• Molecular analysis of the regulation of nisin immunity.

  1996cited by this paper
• Protein engineering of lantibiotics

  1996cited by this paper
• The Antistaphylococcal Effect of Nisin in a Suitable Vehicle: A Potential Therapy for Atopic Dermatitis in Man

  1996cited by this paper
• The structure of the lantibiotic lacticin 481 produced by Lactococcus lactis: location of the thioether bridges

  1996cited by this paper
• Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants

  1996cited by this paper
• Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5

  1996cited by this paper
• Comparison of lantibiotic gene clusters and encoded proteins

  1996cited by this paper
• Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study.

  1996cited by this paper
• Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci.

  1996cited by this paper
• Structure‐activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin

  1996cited by this paper
• Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5

  1996cited by this paper
• Applications of the bacteriocin, nisin

  1996cited by this paper
• A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes.

  1995cited by this paper
• Role of the Leader and Structural Regions of Prelantibiotic Peptides as Assessed by Expressing Nisin-Subtilin Chimeras in Bacillus subtilis 168, and Characterization of their Physical, Chemical, and Antimicrobial Properties (*)

  1995cited by this paper
• Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering

  1995cited by this paper
• Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry

  1995cited by this paper
• Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?

  1995cited by this paper
• Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD.

  1994cited by this paper
• Duplication of the lantibiotic structural gene in M-type 49 group A streptococcus strains producing streptococcin A-M49

  1994cited by this paper
• Construction of an expression system for engineering of the lantibiotic Pep5

  1994cited by this paper
• Solution structures of the lantibiotics duramycin B and C.

  1993cited by this paper
• The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs.

  1993cited by this paper
• A novel post-translational modification of the peptide antibiotic subtilin: isolation and characterization of a natural variant from Bacillus subtilis A.T.C.C. 6633.

  1993cited by this paper
• Properties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis

  1993cited by this paper
• Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin

  1992cited by this paper
• Evaluation of a nisin-based germicidal formulation on teat skin of live cows.

  1992cited by this paper
• Solution structures of nisin A and its two major degradation products determined by n.m.r.

  1992cited by this paper
• Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis.

  1992cited by this paper
• Engineering dehydrated amino acid residues in the antimicrobial peptide nisin.

  1992cited by this paper
• The solution structure of the lantibiotic gallidermin

  1991cited by this paper
• Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.

  1991cited by this paper
• Identification and characterization of the lantibiotic nisin Z, a natural nisin variant.

  1991cited by this paper
• Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.

  1990cited by this paper
• Nisin inhibits several gram-positive, mastitis-causing pathogens.

  1989cited by this paper
• Gallidermin: a new lanthionine-containing polypeptide antibiotic.

  1988cited by this paper
• Isolation and characterization of ancovenin, a new inhibitor of angiotensin I converting enzyme, produced by actinomycetes.

  1983cited by this paper
• Binding of bacitracin to cells and protoplasts of Micrococcus lysodeikticus.

  1974cited by this paper
• The number and nature of , -unsaturated amino acids in subtilin.

  1973cited by this paper
• Residence time of nisin in the oral cavity following consumption of chocolate milk containing nisin.

  1966cited by this paper

• A comparative framework of natural nisin variants: linking genetic basis to future bioengineering applications.

  2026cites this paper
• Designing of a novel chimeric antimicrobial peptide against Acinetobacter baumannii using three different bioinformatics methods and evaluation of its antimicrobial activity in vitro

  2025cites this paper
• Mechanistic Insights into the Structural Asymmetry of the LanFEG Transporter NisFEG in Lantibiotic Immunity

  2025cites this paper
• A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity

  2025cites this paper
• Kinetic Analysis of Lanthipeptide Cyclization by Substrate-Tolerant ProcM

  2024cites this paper
• Unlocking the power of postbiotics: A revolutionary approach to nutrition for humans and animals.

  2024cites this paper
• Approach advancements for engineering novel peptide analogs of existing lantibiotics: where are we today?

  2024cites this paper
• Kinetic Analysis of Cyclization by the Substrate-Tolerant Lanthipeptide Synthetase ProcM

  2024cites this paper
• Probiotics and Their Potential for the Prevention and Treatment of Infections

  2024cites this paper
• The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens

  2023cites this paper
• Rise of bacterial small proteins and peptides in therapeutic applications.

  2023cites this paper
• Metabolic signature of cervical mucus in ewe breeds with divergent cervical sperm transport: a focus on metabolites involved in amino acid metabolism

  2023cites this paper
• Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.

  2022cites this paper
• Antimicrobial Peptides as Immunomodulators and Antimycobacterial Agents to Combat Mycobacterium tuberculosis: a Critical Review

  2022cites this paper
• Molecular Mass Determination of Bacteriocin by SDS-PAGE Analysis

  2022cites this paper
• Assessment of Bacteriocin-Antibiotic Synergy for the Inhibition and Disruption of Biofilms of Listeria monocytogenes and Vancomycin-Resistant Enterococcus

  2022influential citation
• The Emerging Role of Probiotics and their Derivatives against Biofilm-Producing MRSA: A Scoping Review

  2022cites this paper
• A review on characterization, applications and structure-activity relationships of Bacillus species-produced bacteriocins.

  2022cites this paper
• LANTIBIOTICS OF MILK ISOLATES: A SHORT REVIEW ON CHARACTERIZATION AND POTENTIAL APPLICATIONS

  2022influential citation
• The antimicrobial peptide AsR416 can inhibit the growth, sclerotium formation and virulence of Rhizoctonia solani AG1-IA

  2021cites this paper
• Regulation of Heterologous Subtilin Production in Bacillus subtilis W168

  2021cites this paper
• Characterization of dual bacteriocins producing Bacillus subtilis SC3.7 isolated from fermented food

  2021cites this paper
• Peptide backbone modifications in lanthipeptides.

  2021cites this paper
• Bio-Engineered Nisin with Increased Anti-Staphylococcus and Selectively Reduced Anti-Lactococcus Activity for Treatment of Bovine Mastitis

  2021cites this paper
• Regulation of heterologous subtilin production in Bacillus subtilis W168

  2021cites this paper
• Simultaneous Production of Multiple Antimicrobial Compounds by Bacillus velezensis ML122-2 Isolated From Assam Tea Leaf [Camellia sinensis var. assamica (J.W.Mast.) Kitam.]

  2021cites this paper
• Lantibiotics Nanotechnology, Bioengineering, and Biotechnology

  2021cites this paper
• A Genome-Wide Analysis of Antibiotic Producing Genes in Streptomyces globisporus SP6C4

  2021cites this paper
• Lactic Acid Bacteria as Antimicrobial Agents: Food Safety and Microbial Food Spoilage Prevention

  2021cites this paper
• Cyclic peptide production from lactic acid bacteria (LAB) and their diverse applications

  2020cites this paper
• Natural Antimicrobial Peptides: An Emerging Therapeutic Agent against Pathogens

  2020cites this paper
• Vancomycin and nisin A are effective against biofilms of multi-drug resistant Staphylococcus aureus isolates from human milk

  2020cites this paper
• Conditions of nisin production by Lactococcus lactis subsp. lactis and its main uses as a food preservative

  2020cites this paper
• Characterization of a Dehydratase and Methyltransferase in the Biosynthesis of Ribosomally Synthesized and Post‐translationally Modified Peptides in Lachnospiraceae

  2020cites this paper
• Characterization of the nucleotide-binding domain NsrF from the BceAB-type ABC-transporter NsrFP from the human pathogen Streptococcus agalactiae

  2020cites this paper
• Genome-Guided Mass Spectrometry Expedited the Discovery of Paraplantaricin TC318, a Lantibiotic Produced by Lactobacillus paraplantarum Strain Isolated From Cheese

  2020cites this paper
• Prevention of Panton-Valentine Toxin-Mediated Leucocyte Destruction Depending on the Ultra-Diluted Staphylococcinum Potency Gradient

  2020cites this paper
• Structural determinants of macrocyclization in substrate-controlled lanthipeptide biosynthetic pathways†

  2020cites this paper
• Metabolomics and microbial biocontrol agents

  2020cites this paper
• An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium

  2020cites this paper
• An engineered double lipid II binding motifs-containing lantibiotic 1 displays potent and selective antimicrobial activity against E. faecium 2

  2020cites this paper
• Kunkecin A, a New Nisin Variant Bacteriocin Produced by the Fructophilic Lactic Acid Bacterium, Apilactobacillus kunkeei FF30-6 Isolated From Honey Bees

  2020cites this paper
• An overview of lantibiotic biosynthetic machinery promiscuity and its impact on antimicrobial discovery

  2020cites this paper
• Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

  2020cites this paper
• Three Bacteriocin Peptides from a lactic acid bacterium Weissella confusa MBF8-1 with Spermicidal Activity.

  2019cites this paper
• Characterization of Subtilin L-Q11, a Novel Class I Bacteriocin Synthesized by Bacillus subtilis L-Q11 Isolated From Orchard Soil

  2019cites this paper
• New antimicrobials to target gut and food pathogens

  2019cites this paper
• Prediction and characterisation of lantibiotic structures with molecular modelling and molecular dynamics simulations

  2019cites this paper
• CylA is a sequence-specific protease involved in toxin biosynthesis

  2019cites this paper
• Reactive Enamines and Imines In Vivo: Lessons from the RidA Paradigm.

  2019cites this paper
• First evidence of production of the lantibiotic nisin P

  2019cites this paper
• Structure and Dynamics of Cinnamycin–Lipid Complexes: Mechanisms of Selectivity for Phosphatidylethanolamine Lipids

  2019cites this paper
• The role of protein-protein interactions in the biosynthesis of ribosomally synthesized and post-translationally modified peptides.

  2019cites this paper
• Crystal Structure of NisI in a Lipid-Free Form, the Nisin Immunity Protein, from Lactococcus lactis

  2018cites this paper
• Characterization of Listeria-active bacteriocin produced by a new strain Lactobacillus plantarum subsp. plantarum SKI19 isolated from “sai krok e-san mu”

  2018cites this paper
• Current developments in lantibiotic discovery for treating Clostridium difficile infection

  2018cites this paper
• Corrigendum: A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut–Blood Barrier?

  2018cites this paper
• Bacteriocin from Streptococcus salivarius optimized statistically by response surface methodology active against different clinical oral pathogenic Streptococci

  2018cites this paper
• Insight into Two ABC Transporter Families Involved in Lantibiotic Resistance

  2018cites this paper
• Anti- S. aureus and Anti- L. monocytogenes Molecules Produced by Cheese-isolated Lactic Acid Bacteria

  2018cites this paper
• Bacteriocins as food preservatives: Challenges and emerging horizons

  2018cites this paper
• Genome mining, isolation, chemical synthesis and biological evaluation of a novel lanthipeptide, tikitericin, from the extremophilic microorganism Thermogemmatispora strain T81† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc02170h

  2018cites this paper
• Recombinant Macrocyclic Lanthipeptides Incorporating Non-Canonical Amino Acids.

  2017cites this paper
• Microorganisms of the Intestinal Microbiota of Oncorhynchus Mykiss Produce Antagonistic Substances Against Bacteria Contaminating Food and Causing Disease in Humans

  2017cites this paper
• Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes

  2017cites this paper
• Lantibiotics produced by Actinobacteria and their potential applications (a Review).

  2017cites this paper
• Bacteriocin-like inhibitory substance (BLIS) activity of Streptococcus macedonicus MBF10-2 and its synergistic action in combination with antibiotics.

  2017cites this paper
• Evolutionary radiation of lanthipeptides in marine cyanobacteria

  2017cites this paper
• Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.

  2017cites this paper
• Characterization of the stereochemical configuration of lanthionines formed by the lanthipeptide synthetase GeoM

  2016cites this paper
• Protein Defense Systems against the Lantibiotic Nisin: Function of the Immunity Protein NisI and the Resistance Protein NSR

  2016cites this paper
• A Review: Lantibiotics, a Promising Antimicrobial Agent

  2016cites this paper
• Trends in utilization of agro-industrial byproducts for production of bacteriocins and their biopreservative applications

  2016cites this paper
• The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300

  2016cites this paper
• Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging

  2016cites this paper
• The Biological Role of Bacteriocins of Gram-Negative Bacteria

  2016cites this paper
• Genetic and Biochemical Analysis of the Micrococcin Biosynthetic Pathway

  2016cites this paper
• Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic

  2016cites this paper
• Le fonctionnement du transporteur ABC de Streptococcus pneumoniae impliqué dans la résistance contre les peptides antimicrobiens

  2016cites this paper
• Insights into the Biosynthesis of Duramycin

  2016cites this paper
• Probiotic potential of lactic acid bacteria isolated from rainbow trout (Oncorhynchus mykiss, Walbaum) and rearing environment. Importance in the prevention of fish diseases and public health

  2016influential citation
• In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms

  2016cites this paper
• Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation

  2016cites this paper
• Towards the Understanding of Fermented Food Biotechnology in Congo Brazzaville

  2016cites this paper
• Structure of the Response Regulator NsrR from Streptococcus agalactiae, Which Is Involved in Lantibiotic Resistance

  2016cites this paper
• Interactions microbiennes et adaptations en milieu extrême : peptides antimicrobiens d’archées halophiles

  2016cites this paper
• Antimicrobial peptides and proteins in the face of extremes: Lessons from archaeocins.

  2015cites this paper
• Lantibiotic Resistance

  2015cites this paper
• Isolation of Lactic Acid Bacteria That Produce Protease and Bacteriocin-Like Substance From Mud Crab (Scylla sp.) Digestive Tract (Isolasi Bakteri Asam Laktat yang Menghasilkan Protease dan Senyawa Bacteriocin-Like dari Saluran Pencernaan Kepiting

  2015cites this paper
• Synergistic binding of the leader and core peptides by the lantibiotic synthetase HalM2.

  2015cites this paper
• Overexpression, purification and crystallization of the response regulator NsrR involved in nisin resistance.

  2015cites this paper
• A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius

  2015cites this paper
• The development of antimicrobial peptides as an approach to prevention of antibiotic resistance

  2015cites this paper
• Therapeutic intervention and molecular characterizations of bacteriocin producing Lysinibacillus sp., nov., isolated from food sample.

  2015cites this paper
• Purification and characterization of a novel bacteriocin CAMT2 produced by Bacillus amyloliquefaciens isolated from marine fish Epinephelus areolatus

  2015cites this paper
• Overexpression, purification, crystallization and preliminary X-ray diffraction of the nisin resistance protein from Streptococcus agalactiae.

  2015cites this paper
• Anti-Mycobacterial Peptides: From Human to Phage

  2015cites this paper
• Biodiversity in production of antibiotics and other bioactive compounds.

  2015cites this paper
• Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.

  2015cites this paper
• Bacteriocins of Food Grade Lactic Acid Bacteria in Hurdle Technology for Milk and Dairy Products

  2015cites this paper